Trial Profile
Clinical effects of indacaterol in patients with COPD
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Indacaterol (Primary) ; Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 15 May 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 01 Apr 2014 Primary endpoint 'Computerised-tomography-changes' has been met.
- 01 Apr 2014 Results published in the Respirology.